Matthew Hawryluk
Director/Board Member bij PREDICTIVE ONCOLOGY INC.
Vermogen: 825 240 $ op 29-02-2024
Profiel
Matthew J.
Hawryluk is on the board of Predictive Oncology, Inc. and Chief Business Officer & Executive Vice President at Gritstone bio, Inc.
Dr. Hawryluk previously was Vice President-Corporate & Business Development at Foundation Medicine, Inc.
Matthew J.
Hawryluk received an undergraduate degree from the University of Notre Dame, a doctorate from the University of Pittsburgh School of Medicine and an MBA from Tepper School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GRITSTONE BIO, INC.
0.30% | 01-02-2024 | 286 880 ( 0.30% ) | 803 264 $ | 29-02-2024 |
PREDICTIVE ONCOLOGY INC
0.18% | 14-11-2023 | 7 135 ( 0.18% ) | 21 976 $ | 29-02-2024 |
Actieve functies van Matthew Hawryluk
Bedrijven | Functie | Begin |
---|---|---|
GRITSTONE BIO, INC. | Corporate Officer/Principal | 01-11-2015 |
PREDICTIVE ONCOLOGY INC. | Director/Board Member | 29-11-2022 |
Eerdere bekende functies van Matthew Hawryluk
Bedrijven | Functie | Einde |
---|---|---|
FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Opleiding van Matthew Hawryluk
University of Notre Dame | Undergraduate Degree |
Tepper School of Business | Masters Business Admin |
University of Pittsburgh School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PREDICTIVE ONCOLOGY INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |